Since 2001, PerkinElmer has provided scientific expertise and instrumentation for the Brawn GP Formula One team's car performance testing program. To accurately measure and monitor engine and gearbox degradation, Brawn GP maintains a PerkinElmer Materials Testing Laboratory at its headquarters in Brackley, UK, where a diverse range of technologies are employed. PerkinElmer has provided Brawn with exclusive access to its Seer Green (UK) demonstration laboratory, as well as support by Product Specialists for troubleshooting as needed.

Speaking of the recent win, Andy Attwood, vice president and general manager, Analytical Sciences and Laboratory Services, Europe, PerkinElmer, noted, "We are proud to be a technical partner to Brawn GP and help to ensure the integrity of the team's cars and the safety of their drivers. "

He continued, "It's a pleasure working with such a wonderful group of people and, on behalf of everyone at PerkinElmer, I would like to congratulate Brawn GP on securing the 2009 FIA Formula One Constructors' Championship at the Brazilian Grand Prix in Interlagos and to Jenson Button for wrapping up the Drivers' Championship before the final race of the season took place."

PerkinElmer's SpectrumTM 100 Series FT-IR spectrometer is used by Brawn GP to monitor degradation of worn seals and analyse organic debris from engine and gearbox lubricants. The universal attenuated total reflectance (ATR) accessory discovers unknown factors that may impact performance. Lubricants are tested using PerkinElmer's OptimaTM 5300V Inductively Coupled Plasma (ICP) instrument to accurately detect metal content and help determine engine or gearbox wear. To help ensure the cars' integrity, PerkinElmer's Jade Differential Scanning Calorimeter (DSC) and Dynamic Mechanical Analyser (DMA) carry out important quality control checks to ensure that adhesives used to bond carbon fibre components have been cured correctly.

PerkinElmer, Inc. is a company focused on improving the health and safety of people and the environment.

((Comments on this story may be sent to newsdesk@closeupmedia.com))

The Company said that the GSP system makes it much easier for labs to analyze newborn blood samples by providing the capability to run more than one test at once on very small samples. The GSP is an automated platform able to quantitatively and qualitatively analyze blood spot samples for irregularities associated with metabolic diseases that when detected early, can often be easily treated. With multi-analyte analysis capability and a two-fold capacity over prior systems, the GSP system delivers increased efficiency and flexibility over other methods, while reducing the risk of errors associated with manual processing of samples.

"FDA approval of PerkinElmer's GSP system provides laboratories in the U.S. with a next-generation system that can help address the staffing and workflow needs of today's demanding environment," said Ann-Christine Sundell, president, Genetic Screening, PerkinElmer. "This achievement reflects our ongoing commitment, as the global leader in newborn screening, to improving medical outcomes by developing the highest quality newborn screening solutions."

((Comments on this story may be sent to health@closeupmedia.com))

Since 2001, PerkinElmer has provided scientific expertise and instrumentation for the Brawn GP Formula One team's car performance testing program. To accurately measure and monitor engine and gearbox degradation, Brawn GP maintains a PerkinElmer Materials Testing Laboratory at its headquarters in Brackley, UK, where a diverse range of technologies are employed. PerkinElmer has provided Brawn with exclusive access to its Seer Green (UK) demonstration laboratory, as well as support by Product Specialists for troubleshooting as needed.

Speaking of the recent win, Andy Attwood, vice president and general manager, Analytical Sciences and Laboratory Services, Europe, PerkinElmer, noted, "We are proud to be a technical partner to Brawn GP and help to ensure the integrity of the team's cars and the safety of their drivers. "

He continued, "It's a pleasure working with such a wonderful group of people and, on behalf of everyone at PerkinElmer, I would like to congratulate Brawn GP on securing the 2009 FIA Formula One Constructors' Championship at the Brazilian Grand Prix in Interlagos and to Jenson Button for wrapping up the Drivers' Championship before the final race of the season took place."

PerkinElmer, Inc. is a global company focused on improving the health and safety of people and the environment. The Company reported revenue of approximately $2 billion in 2008, has around 8,500 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index.

((Comments on this story may be sent to health@closeupmedia.com))

Dr. Richard M. Eglen, president, Bio-discovery, PerkinElmer, said, "Collaborating with a world-renowned company such as Corning provides a key opportunity to combine Corning's innovative optical label-free detection technology with PerkinElmer's existing multi-label detection systems to provide drug discovery and life science researchers with deeper insights into biomolecular and cellular interactions."

"Scientists around the world have used the optical label-free technology of the Corning Epic system for their groundbreaking research and we have been pleased with the new biological discoveries that the technology has enabled," said Mark A. Beck, senior vice president, Corning Life Sciences. "We are excited to be working with an industry leader like PerkinElmer to develop next-generation label-free technologies in order to create the potential for additional breakthrough discoveries."

((Comments on this story may be sent to newsdesk@closeupmedia.com))